Our clients range from pre-revenue early-stage biotech companies, to large cap pharma and medical device multinationals, to CROs covering everything! We’ve supported studies as small as one site, to as large as 300+ sites around the globe.
EXPERIENCE
At Galen, we work on studies of all different types and sizes.
Here are just some of the categories we’ve covered through the years.
- Aesthetics
- Allergy/Immunology
- Bariatrics
- Cardiology
- Chronic Pain
- CNS
- Dermatology
- Diagnostics
- Digestive Health
- Endocrinology
- ENT
- Gastroenterology
- Men’s Health
- Movement Disorders
- Nephrology
- Neurology
- OB-GYN
- Ophthalmology
- Orthopaedics
- Pediatrics
- Podiatry
- Psychiatry
- Pulmonology
- Rare Diseases
- Reproductive Health
- Rheumatology
- Sleep Medicine
- Spine
- Sports Medicine
- Urology
- Vascular Disease
- Women’s Health
CASE STUDIES
Over 15 years, it’s hard to select just a few studies to showcase our breadth and depth of experience. Chances are, whatever patient indication you’re looking to recruit, we have a case study for you! Please contact us and we’ll be happy to follow-up with you directly about your specific needs:
Atopic Dermatitis (Adult & Pediatric) Phase III
Situation/Client Recruitments
- Many sites with competing trials
- Aggressive enrollment timeline, high profile program within company
Results
- Enrollment completed 4 months ahead of schedule
- Delivered 74% of all randomizations
Morbid Obesity IDE
Situation/Client Recruitments
- Procedure vs. sham
- Limited recruitment budget
- Aggressive enrollment timeline
Results
- Beat enrollment timeline by 2.5 months
- Generated 82% of all randomizations
- Total investment 1/10 of competitive proposal
PTSD Phase III
Situation/Client Recruitments
- Difficult to engage patient population
- Many sites entirely dependent on recruitment program for candidates
Results
- Delivered 58% of all randomizations
- Enrollment completed 3 months ahead of schedule
Hyperhidrosis IDE
Situation/Client Recruitments
- Procedure vs. sham
- Narrow inclusion criteria
- Treatment dates set in stone, putting added pressure on recruitment timing/throughput
Results
- Halved enrollment timeline
- Delivered 90% of all randomizations
- Total expenditure well below budget, and at fraction of competitive proposal
Prurigo Nodularis Phase III
Situation/Client Recruitments
- Rare dermatology population
- Many sites dependent on recruitment program for candidates
- Several EU sites new to patient recruitment campaigns
Results
- Delivered 48% of all randomizations
- Among EU sites new to patient recruitment campaigns, delivered 62% of all randomizations
Lumbar Spinal Stenosis IDE
Situation/Client Recruitments
- Surgical randomization
- 400 subjects needed – enrolled 55 over 12 months prior to engaging Galen
- Immovable deadline for enrollment completion
Results
- Delivered 56% of all randomizations
- For highest enrolling site, delivered 32 of 35 (91%) enrolled subjects
- Beat immovable deadline by 1.5 months
Overactive Bladder Phase IIB
Situation/Client Recruitments
- Narrow I/E criteria
- Aggressive enrollment deadline tied to company fundraising
- Multiple recruitment vendors tried prior to Galen
Results
- Within 2 months, generated 245 randomizations
- During these 2 months, 79% of all randomizations generated via Galen
- Study completed on time and below budget